Cargando…

The versatile nature of miR-9/9(*) in human cancer

miR-9 and miR-9(*) (miR-9/9(*)) were first shown to be expressed in the nervous system and to function as versatile regulators of neurogenesis. The variable expression levels of miR-9/9(*) in human cancer prompted researchers to investigate whether these small RNAs may also have an important role in...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowek, Katarzyna, Wiemer, Erik A.C., Jongen-Lavrencic, Mojca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945517/
https://www.ncbi.nlm.nih.gov/pubmed/29755694
http://dx.doi.org/10.18632/oncotarget.24889
_version_ 1783322004891369472
author Nowek, Katarzyna
Wiemer, Erik A.C.
Jongen-Lavrencic, Mojca
author_facet Nowek, Katarzyna
Wiemer, Erik A.C.
Jongen-Lavrencic, Mojca
author_sort Nowek, Katarzyna
collection PubMed
description miR-9 and miR-9(*) (miR-9/9(*)) were first shown to be expressed in the nervous system and to function as versatile regulators of neurogenesis. The variable expression levels of miR-9/9(*) in human cancer prompted researchers to investigate whether these small RNAs may also have an important role in the deregulation of physiological and biochemical networks in human disease. In this review, we present a comprehensive overview of the involvement of miR-9/9(*) in various human malignancies focusing on their opposing roles in supporting or suppressing tumor development and metastasis. Importantly, it is shown that the capacity of miR-9/9(*) to impact tumor formation is independent from their influence on the metastatic potential of tumor cells. Moreover, data suggest that miR-9/9(*) may increase malignancy of one cancer cell population at the expense of another. The functional versatility of miR-9/9(*) emphasizes the complexity of studying miRNA function and the importance to perform functional studies of both miRNA strands in a relevant cellular context. The possible application of miR-9/9(*) as targets for miRNA-based therapies is discussed, emphasizing the need to obtain a better understanding of the functional properties of these miRNAs and to develop safe delivery methods to target specific cell populations.
format Online
Article
Text
id pubmed-5945517
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-59455172018-05-13 The versatile nature of miR-9/9(*) in human cancer Nowek, Katarzyna Wiemer, Erik A.C. Jongen-Lavrencic, Mojca Oncotarget Review miR-9 and miR-9(*) (miR-9/9(*)) were first shown to be expressed in the nervous system and to function as versatile regulators of neurogenesis. The variable expression levels of miR-9/9(*) in human cancer prompted researchers to investigate whether these small RNAs may also have an important role in the deregulation of physiological and biochemical networks in human disease. In this review, we present a comprehensive overview of the involvement of miR-9/9(*) in various human malignancies focusing on their opposing roles in supporting or suppressing tumor development and metastasis. Importantly, it is shown that the capacity of miR-9/9(*) to impact tumor formation is independent from their influence on the metastatic potential of tumor cells. Moreover, data suggest that miR-9/9(*) may increase malignancy of one cancer cell population at the expense of another. The functional versatility of miR-9/9(*) emphasizes the complexity of studying miRNA function and the importance to perform functional studies of both miRNA strands in a relevant cellular context. The possible application of miR-9/9(*) as targets for miRNA-based therapies is discussed, emphasizing the need to obtain a better understanding of the functional properties of these miRNAs and to develop safe delivery methods to target specific cell populations. Impact Journals LLC 2018-04-17 /pmc/articles/PMC5945517/ /pubmed/29755694 http://dx.doi.org/10.18632/oncotarget.24889 Text en Copyright: © 2018 Nowek et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Review
Nowek, Katarzyna
Wiemer, Erik A.C.
Jongen-Lavrencic, Mojca
The versatile nature of miR-9/9(*) in human cancer
title The versatile nature of miR-9/9(*) in human cancer
title_full The versatile nature of miR-9/9(*) in human cancer
title_fullStr The versatile nature of miR-9/9(*) in human cancer
title_full_unstemmed The versatile nature of miR-9/9(*) in human cancer
title_short The versatile nature of miR-9/9(*) in human cancer
title_sort versatile nature of mir-9/9(*) in human cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945517/
https://www.ncbi.nlm.nih.gov/pubmed/29755694
http://dx.doi.org/10.18632/oncotarget.24889
work_keys_str_mv AT nowekkatarzyna theversatilenatureofmir99inhumancancer
AT wiemererikac theversatilenatureofmir99inhumancancer
AT jongenlavrencicmojca theversatilenatureofmir99inhumancancer
AT nowekkatarzyna versatilenatureofmir99inhumancancer
AT wiemererikac versatilenatureofmir99inhumancancer
AT jongenlavrencicmojca versatilenatureofmir99inhumancancer